Cargando…
Improved treatment of early small hepatocellular carcinoma using sorafenib in combination with radiofrequency ablation
Small hepatocellular carcinoma is an important leading cause of death amongst cancer patients, our study was designed in order to test the hypothesis that radiofrequency ablation (RFA) combined with a chemotherapeutic drug would improve the outcome for patients. Two groups of patients presenting ear...
Autores principales: | Gong, Quanyou, Qin, Zhaoxia, Hou, Fangli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754899/ https://www.ncbi.nlm.nih.gov/pubmed/29344133 http://dx.doi.org/10.3892/ol.2017.7174 |
Ejemplares similares
-
The clinical effect and relevant mechanism of combined sorafenib and radiofrequency ablation in the treatment of early small hepatocellular carcinoma
por: Yan, Shi-Yan, et al.
Publicado: (2016) -
Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy
por: Wei, Meng-Chao, et al.
Publicado: (2022) -
Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma
por: Song, Myeong Jun, et al.
Publicado: (2016) -
Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation
por: Dong, Shuying, et al.
Publicado: (2015) -
Radiofrequency Ablation Combined With Transarterial Chemoembolization for
Specially Located Small Hepatocellular Carcinoma
por: Yuan, Wei, et al.
Publicado: (2018)